Amryt Pharma PLC (LON:AMYT) has been awarded rare paediatric disease designation for AP101 by the US Food & Drug Administration. Currently undergoing phase III clinical trials, the cream is being developed to treat Epidermolysis Bullosa (EB), a condition which occurs prominently in children and makes skin fragile to even the faintest touch.
Ceres Power Holdings PLC (LON:CWR) is to receive £7mln in funding to continue work with Nissan on fuel cell technology for electric vehicle applications.
Hurricane Energy PLC (LON:HUR) has reached what is described as a ‘critical milestone’ in the development of the Lancaster field’s early production system (EPS), completing the installation of a turret mooring system. It included the connection to the newly-constructed buoy for the Aoka Mizu floating production, storage and offloading (FPSO) vessel.
Advanced Oncotherapy (LON:AVO), the developer of proton beam systems used to treat cancer, has completed a share placing with Swiss investors that has brought in £6.41mln. Shares were issued at 49p each, which was a modest discount to last night’s closing price of 51p, with a number of prominent private banks and healthcare providers buying into the company.
NetScientific PLC (LON:NSCI) said its portfolio company, ProAxsis Limited, has registered a CE mark for an immunoassay to help research respiratory diseases.
Concepta PLC (LON:CPT) has raised £2mln in an oversubscribed share placing to fund the expansion of its myLotus product in the Chinese market.
Frontier IP Group Plc (LON:FIPP) said it has partnered with the UK’s Department for International Trade (DIT) to step up its presence in Portugal.
European Wealth Group Limited (LON:EWG) said major shareholder Astoria Investments has subscribed for 7.92mln shares at 16.5p each, raising £1.31mln for the company and lifting Astoria's stake from 13.7% to 18%.
Metminco Limited (LON:MNC) (ASX:MNC) has announced the appointment of Nick Winer to the role of director of exploration, based in Medellin, Colombia. Winer is a geologist with over 30 years' experience in gold, base metals in South America and will lead the company's activities in Colombia, in particular, the advancement of the portfolio of gold assets in the Quinchia district.
IronRidge Resources PLC (LON:IRR) has carried out an additional 1,000m of drilling at Ewoyaa in Ghana after discovering extensions of lithium-bearing pegmatite not visible on the surface. Len Kolff, IronRidge’s chief geologist said: "Drilling has identified a new pegmatite extension to the central Main Zone with an additional 400m strike length of pegmatite drilled and still open to the north, that has no obvious surface expression and occurs within a valley below recent sediment cover.
A further planning roadblock has been revealed for the Wressle oil project onshore UK, in Lincolnshire, where the latest decision has gone against the group of companies hoping to bring the new field into production. Europa Oil & Gas Holdings PLC (LON:EOG) hold a 30% stake in Wressle; Union Jack Oil PLC (LON:UJO) retains a 27.5% stake.
Shares in Cadence Minerals Plc (LON:KDNC) rose on Wednesday after it flagged a statement from Auroch Minerals, in which it has a 7% stake. Auroch Minerals (ASE:AOU) has started drilling at its Arden base-metals project in South Australia.
Mosman Oil And Gas Limited (LON:MSMN) the oil exploration, development and production company, has appointed SVS Securities as joint broker to the company, effective immediately. The group said SP Angel remains its nominated adviser and joint broker.
CentralNic Group PLC (LON:CNIC), the internet platform that derives revenue from the worldwide sales of internet domain names and associated web presence services, has said the acquisition of KeyDrive SA and associated placing of 46,153,847 new ordinary shares to raise approximately £24mln, announced on 16 July 2018, are now complete. Ben Crawford, CentralNic's CEO, said: "The transaction is a milestone in the Company's history as it cements CentralNic's position as a consolidator in the market to rival its competitors, including large and influential US players."
Capital Network has issued a report on Avacta PLC in which analyst Riccardo Lowi notes that, despite the favourable reaction to the recent Bach Biosciences agreement, Avacta’s market capitalisation is still much lower than biotech peers that have unique protein-based platforms and drug candidates in the clinical stage, where the group is on track to be by 2020.